Evidence map›Paper›PMID 40963863›Full record

ArticleFrontiers in oncology2025

Long-term survival in a male patient with Müllerian adenocarcinoma of the pelvis: a 15-year case report.

Girolamo Ranieri, Mariangela Porcelli, Alessandro Mastrorosa, Alessandra Di Palo, Cristina Ferrari, Alfredo Francesco Zito, Michele Ammendola, Carmelo Laface, Giovanni Mastrandrea, Simona Berardone

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Girolamo RanieriUnità Operativa di Oncologia Integrata, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Mariangela PorcelliUnità Operativa di Oncologia Integrata, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Alessandro MastrorosaUnità Operativa di Oncologia Urologica, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Alessandra Di PaloUnità Operativa di Medicina Nucleare,Università di Bari "Aldo Moro", Bari, Italy.
Cristina FerrariUnità Operativa di Medicina Nucleare,Università di Bari "Aldo Moro", Bari, Italy.
Alfredo Francesco ZitoUnità Operativa di Anatomia Patologica, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Michele AmmendolaUnità Operativa di Chirurgia dell'Apparato Digerente, Università "Magna Grecia", Catanzaro, Italy.
Carmelo LafaceUnità Operativa di Oncologia Integrata, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Giovanni MastrandreaUnità Operativa Complessa di Anestesia, Rianimazione e Terapia Intensiva Postoperatoria, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Simona BerardoneUnità Operativa di Oncologia Integrata, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Müllerian adenocarcinoma is a very rare and aggressive cancer originating from the uterus and ovary, affecting almost exclusively women. Few cases of extragenital Müllerian adenocarcinomas have been reported, in various locations ranging from pelvic peritoneum to diaphragm peritoneum. Very few cases of Müllerian adenocarcinoma in men have been reported in scientific literature, usually localized in the prostate seminal vesicles and testicles, associated to a very poor prognosis. Case summary: In this paper, we describe the unique clinical case of a man affected by advanced Müllerian adenocarcinoma on the left side of the pelvis, treated with a combination of surgery, chemotherapy, and radiotherapy, with a long follow-up. Patient survival was exceptional (almost 15 years from diagnosis), and the patient experienced a good quality of life during the numerous treatments. To the best of our knowledge, this is the first case report regarding a Müllerian adenocarcinoma of the pelvis in a man treated with a multimodal therapy approach and with a very long follow-up and very long survival. In consideration of the embryological origin of ovaries from Müllerian ducts and the absence of specific guidelines for standard treatment for this tumor, the patient was treated as if he had ovarian cancer, with optimal results. Conclusions: The management of this patient with modern available lines of chemotherapy classically employed in ovarian cancer plus radiotherapy combined with several bouts of cytoreductive surgery could explain this long survival.

Indexed as

case reportlong survivalMüllerian adenocarcinoma in malemultimodal oncology therapypelvis

Identifiers

PMID40963863
PMCPMC12436133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.